| TELO Stock | | | CAD 0.11 0.01 8.33% |
Telo Genomics financial indicator trend analysis is much more than just breaking down Telo Genomics Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Telo Genomics Corp is a good investment. Please check the relationship between Telo Genomics Non Current Assets Total and its Common Stock Shares Outstanding accounts. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Telo Genomics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in persons.
Non Current Assets Total vs Common Stock Shares Outstanding
Non Current Assets Total vs Common Stock Shares Outstanding Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Telo Genomics Corp Non Current Assets Total account and
Common Stock Shares Outstanding. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Telo Genomics' Non Current Assets Total and Common Stock Shares Outstanding is -0.49. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Common Stock Shares Outstanding in the same time period over historical financial statements of Telo Genomics Corp, assuming nothing else is changed. The correlation between historical values of Telo Genomics' Non Current Assets Total and Common Stock Shares Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Telo Genomics Corp are associated (or correlated) with its Common Stock Shares Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Shares Outstanding has no effect on the direction of Non Current Assets Total i.e., Telo Genomics' Non Current Assets Total and Common Stock Shares Outstanding go up and down completely randomly.
Correlation Coefficient | -0.49 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.
Most indicators from Telo Genomics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Telo Genomics Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Telo Genomics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in persons.
Issuance Of Capital Stock is likely to climb to about 3.4
M in 2024, whereas
Selling General Administrative is likely to drop slightly above 1.6
M in 2024.
Telo Genomics fundamental ratios Correlations
Click cells to compare fundamentals
Telo Genomics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Telo Genomics fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Telo Stock Analysis
When running Telo Genomics' price analysis, check to
measure Telo Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telo Genomics is operating at the current time. Most of Telo Genomics' value examination focuses on studying past and present price action to
predict the probability of Telo Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telo Genomics' price. Additionally, you may evaluate how the addition of Telo Genomics to your portfolios can decrease your overall portfolio volatility.